NeueHealth (NEUE) News Today

$5.99
-0.13 (-2.12%)
(As of 05/17/2024 ET)
Financial Survey: NeueHealth (NEUE) & Its Peers
Contrasting NeueHealth (NEUE) and Its Competitors
NeueHealth (NEUE) vs. Its Peers Financial Analysis
NeueHealth, Inc. (NYSE:NEUE) Sees Large Decline in Short Interest
NeueHealth, Inc. (NYSE:NEUE - Get Free Report) was the target of a significant decline in short interest in April. As of April 30th, there was short interest totalling 21,300 shares, a decline of 49.5% from the April 15th total of 42,200 shares. Based on an average trading volume of 11,700 shares, the short-interest ratio is presently 1.8 days.
Financial Survey: NeueHealth (NEUE) versus Its Rivals
Q1 2024 NeueHealth Inc Earnings Call
Head-To-Head Survey: NeueHealth (NEUE) and Its Rivals
Comparing NeueHealth (NEUE) and Its Competitors
NeueHealth (NEUE) and Its Competitors Critical Analysis
NeueHealth Q1 Revenue Drops
NeueHealth: Q1 Earnings Snapshot
NeueHealth Reports First Quarter 2024 Results
NeueHealth (NEUE) Set to Announce Quarterly Earnings on Wednesday
NeueHealth (NYSE:NEUE) will be releasing earnings before the market opens on Wednesday, May 8, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=586102)
NeueHealth (NYSE:NEUE) Shares Up 6.7%
NeueHealth (NYSE:NEUE) Trading 6.7% Higher
NeueHealth CEO sells shares worth over $36k
Insider Selling: NeueHealth, Inc. (NYSE:NEUE) CEO Sells 4,990 Shares of Stock
NeueHealth, Inc. (NYSE:NEUE - Get Free Report) CEO George Lawrence Mikan III sold 4,990 shares of NeueHealth stock in a transaction dated Monday, March 18th. The shares were sold at an average price of $7.27, for a total transaction of $36,277.30. Following the sale, the chief executive officer now owns 64,832 shares of the company's stock, valued at $471,328.64. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.
NeueHealth CEO sells over $41k in company stock
George Lawrence Mikan III Sells 7,886 Shares of NeueHealth, Inc. (NYSE:NEUE) Stock
NeueHealth, Inc. (NYSE:NEUE - Get Free Report) CEO George Lawrence Mikan III sold 7,886 shares of the firm's stock in a transaction on Thursday, March 7th. The shares were sold at an average price of $9.88, for a total transaction of $77,913.68. Following the completion of the transaction, the chief executive officer now directly owns 88,483 shares of the company's stock, valued at $874,212.04. The sale was disclosed in a document filed with the SEC, which is available through the SEC website.
Get NeueHealth News Delivered to You Automatically

Sign up to receive the latest news and ratings for NEUE and its competitors with MarketBeat's FREE daily newsletter.

The Overlooked Retirement Asset You Probably Don’t Own (Ad)

4 out of 5 Americans believe we’re on the brink of a retirement crisis. Luckily, in these unprecedented times, we have an unprecedented solution. Once considered a “fringe” investment, the crypto market is now taking the world by storm.

Click here to access the Crypto Retirement Blueprint now.

NEUE Media Mentions By Week

NEUE Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

NEUE
News Sentiment

-0.29

0.42

Average
Medical
News Sentiment

NEUE News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

NEUE Articles
This Week

5

3

NEUE Articles
Average Week

Get NeueHealth News Delivered to You Automatically

Sign up to receive the latest news and ratings for NEUE and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NYSE:NEUE) was last updated on 5/19/2024 by MarketBeat.com Staff

From Our Partners